Table 2.

Characteristics of various studies on surgical procedures for myopic macular hole with retinal detachment

Trial, year	Vital dyes	Area of ILM peeling	Type of tamponade gas	Face-down duration	Other treatment	Intraoperative and postoperative complications
Ikuno (2003) [14]	ICG	2–3 DD	14 % or 16 % C3F8	2 weeks	No	Posterior capsule opacification Cataract Recurrent RD
Lam (2006) [15]	ICG	3–4 DD	12 % C3F8/air mixture	7–10 days	Endolaser at the MH margin	Suprachoroidal hemorrhage Iatrogenic retinal breaks Cataract Glaucoma
Li KK (2010) [17]	TA and 0.15 % trypan blue	Between superotemporal and inferotemporal vascular arcades	14 % C3F8	2 weeks	No	Transient increased IOP
Li X (2009) [9]	TA or ICG	NA	14 % C3F8/air mixture	3 weeks	No	Iatrogenic retinal tear Elevated IOP
Nakanishi (2008) [10]	TA and ICG	NA	SF6 or C3F8	At least 1 week	No	Iatrogenic retinal breaks Temporary elevations of IOP Vitreous hemorrhage
Uemoto (2004) [18]	0.25 % ICG	Within the vascular arcade	24 % SF6 or 14 % C3F8 or room air	1 week	No	Iatrogenic retinal breaks Epiretinal membrane Nuclear cataract
Wei (2013) [16]	TA ± 0.5 % ICG ±	3–4 DD	14 % C3F8/air mixture	2 weeks	No	Retinal breaks Epiretinal membrane MH reopen Cataract Glaucoma

DD disc diameter, ICG indocyanine green, ILM internal limiting membrane, IOP intraocular pressure, MH macular hole, NA not available, TA triamcinolone acetonide